<?xml version="1.0" encoding="UTF-8"?>
<p>Protease inhibitors target viral nsps needed for its replication, such as the RNA-dependent RNA polymerase (RdRp) inhibited by ribavirin (which also inhibits viral mRNA capping); the 3C-like protease (3CLpro) is inhibited by the lopinavir-ritonavir combination (
 <xref rid="b48-ijmm-46-02-0489" ref-type="bibr">48</xref>), which seems to have better results compared to ribavirin, which was associated with anemia, hypoxia and increased risk of death in SARS patients (
 <xref rid="b61-ijmm-46-02-0489" ref-type="bibr">61</xref>).
</p>
